We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+23.31%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$916M
AUM Growth
+$200M
Cap. Flow
+$82.6M
Cap. Flow %
9.02%
Top 10 Hldgs %
26.61%
Holding
112
New
9
Increased
29
Reduced
6
Closed
6

Top Buys

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$17.7M
2
TRN icon
Trinity Industries
TRN
+$17.1M
3
SPLK
Splunk Inc
SPLK
+$9.6M
4
NRG icon
NRG Energy
NRG
+$6.27M
5
XPO icon
XPO
XPO
+$6.11M

Top Sells

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$15.5M
2
MDVN
MEDIVATION, INC.
MDVN
+$6.68M
3
AKBA icon
Akebia Therapeutics
AKBA
+$3.68M
4
CBST
CUBIST PHARMACEUTICALS INC
CBST
+$1.92M
5
ARWR icon
Arrowhead Research
ARWR
+$1.69M

Sector Composition

Rank Sector Weight
1 Healthcare 31.22%
2 Technology 16.49%
3 Consumer Discretionary 14.21%
4 Industrials 9.04%
5 Energy 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLUE
1
DELISTED
bluebird bio
BLUE
$35.8M 3.9%
30,108
-440
-1% -$294K
AGIO icon
2
Agios Pharmaceuticals
AGIO
$1.95B
$28.9M 3.16%
258,200
-173,400
-40% -$15.5M
PANW icon
3
Palo Alto Networks
PANW
$265B
$25.2M 2.75%
1,233,600
– –
RHT
4
DELISTED
Red Hat Inc
RHT
$23.2M 2.53%
335,400
+67,800
+25% +$4.1M
LOW icon
5
Lowe's Companies
LOW
$118B
$22.9M 2.5%
332,500
+26,900
+9% +$1.61M
MGA icon
6
Magna International
MGA
$19B
$22.8M 2.49%
419,200
+119,800
+40% +$6.06M
ABBV icon
7
AbbVie
ABBV
$455B
$21.6M 2.36%
330,700
– –
CELG
8
DELISTED
Celgene Corp
CELG
$21.3M 2.32%
190,000
– –
FPRX
9
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$21.2M 2.31%
784,000
+10,400
+1% +$179K
MDVN
10
DELISTED
MEDIVATION, INC.
MDVN
$21M 2.3%
422,200
-128,400
-23% -$6.68M
TRW
11
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
$20.4M 2.23%
198,400
– –
MIC
12
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$19.6M 2.14%
275,200
+20,000
+8% +$1.36M
WBC
13
DELISTED
WABCO HOLDINGS INC.
WBC
$19.4M 2.12%
185,500
+38,400
+26% +$3.8M
DYAX
14
DELISTED
DYAX CORPORATION
DYAX
$18.7M 2.04%
1,330,400
– –
MNDT
15
DELISTED
Mandiant, Inc. Common Stock
MNDT
$18.2M 1.98%
+575,600
New +$17.7M
LEA icon
16
Lear
LEA
$7.33B
$18.1M 1.97%
184,300
+23,400
+15% +$2.15M
CMRX
17
DELISTED
Chimerix, Inc.
CMRX
$16.9M 1.84%
418,600
– –
DATA
18
DELISTED
Tableau Software, Inc.
DATA
$16.4M 1.79%
193,600
+23,500
+14% +$1.87M
SUNE
19
DELISTED
SUNEDISON, INC COM
SUNE
$15.5M 1.69%
794,600
+65,500
+9% +$1.24M
WAB icon
20
Wabtec
WAB
$49.4B
$15.2M 1.66%
174,700
+30,000
+21% +$2.53M
TRN icon
21
Trinity Industries
TRN
$2.73B
$14.3M 1.56%
+708,390
New +$17.1M
CPN
22
DELISTED
Calpine Corporation
CPN
$14.1M 1.54%
637,300
+39,600
+7% +$879K
IPHI
23
DELISTED
INPHI CORPORATION
IPHI
$13.8M 1.51%
747,400
+63,200
+9% +$925K
ACAD icon
24
Acadia Pharmaceuticals
ACAD
$4.55B
$13.4M 1.47%
423,200
– –
VCYT icon
25
Veracyte
VCYT
$4.77B
$13.4M 1.46%
1,384,100
+467,100
+51% +$3.65M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2014 Portfolio in Review

As of Q4 2014, Eventide Asset Management held 112 positions worth $916M, up 28% from $716M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management deployed $82.6M of net new capital in Q4 2014, opening 9 new positions and adding to 29 existing holdings. Its largest new stake was Mandiant, Inc. Common Stock: 575,600 shares worth $18.2M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $15.5M trimmed.

  • Eventide Asset Management's largest Q4 2014 buy was Mandiant, Inc. Common Stock: 575,600 shares worth $18.2M.
  • Eventide Asset Management added most to NRG Energy in Q4 2014, an estimated $6.27M increase.
  • Eventide Asset Management's biggest Q4 2014 reduction was Agios Pharmaceuticals, cutting an estimated $15.5M.
  • Eventide Asset Management fully exited Akebia Therapeutics in Q4 2014, selling an estimated $3.68M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $916M portfolio in Q4 2014.
  • Eventide Asset Management opened 9 new positions and closed 6 in Q4 2014.
  • Eventide Asset Management's portfolio value rose 28% quarter-over-quarter to $916M.

Based on Eventide Asset Management's 13F filing for Q4 2014, filed 12 Feb 2015.